Phenominer Database Results (34 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
LH/Mav body weight vehicle control condition Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112.0 days 11 384.0 g 9.0 29.85 body weighing method 0.0 102724 2721
LH/Mav body weight controlled perindopril content drinking water (1.5 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119.0 days 8 380.0 g 10.0 28.28 body weighing method 0.0 103406 2824
LH/Mav body weight controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84.0 days 12 318.0 g 8.0 27.71 body weighing method 0.0 103427 2825
LH/Mav body weight perindopril (0.4 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 8 459.0 g 10.0 28.28 body weighing method 0.0 102804 2723
LH/Mav body weight perindopril (0.04 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 6 457.0 g 11.0 26.94 body weighing method 0.0 102807 2723
LH/Mav body weight streptozotocin (75 mg/kg) Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. body mass male 49.0 days-56.0 days 37 233.0 g 4.0 24.33 body weighing method 0.0 102643 2703
LH/Mav body weight perindopril (0.4 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 8 405.0 g 7.0 19.8 body weighing method 0.0 102790 2723
LH/Mav body weight controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119.0 days 6 362.0 g 8.0 19.6 body weighing method 0.0 103407 2824
LH/Mav body weight control condition (for 84 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84.0 days 12 353.0 g 8.0 27.71 body weighing method 0.0 103424 2825
LH/Mav body weight controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147.0 days-154.0 days 6 436.0 g 8.0 19.6 body weighing method 0.0 103431 2825
LH/Mav body weight control condition (for 0 hours) Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. body mass male 84.0 days 5 360.0 g 6.0 13.42 body weighing method 0.0 103479 2826
LH/Mav body weight perindopril (0.04 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 6 372.0 g 9.0 22.05 body weighing method 0.0 102793 2723
LH/Mav body weight controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119.0 days 7 407.0 g 9.0 23.81 body weighing method 0.0 103404 2824
LH/Mav body weight controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and controlled reserpine content drinking water (0.75 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119.0 days 7 383.0 g 7.0 18.52 body weighing method 0.0 103408 2824
LH/Mav body weight controlled losartan content drinking water (10 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84.0 days 13 340.0 g 5.0 18.03 body weighing method 0.0 103425 2825
LH/Mav body weight control condition (between 147 and 154 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147.0 days-154.0 days 6 433.0 g 7.0 17.15 body weighing method 0.0 103428 2825
LH/Mav body weight controlled losartan content drinking water (10 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147.0 days-154.0 days 5 432.0 g 11.0 24.6 body weighing method 0.0 103429 2825
LH/Mav body weight control condition Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 4 431.0 g 8.0 16.0 body weighing method 0.0 102805 2723
LH/Mav body weight perindopril (0.04 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 8 394.0 g 4.0 11.31 body weighing method 0.0 102788 2723
LH/Mav body weight vehicle control condition Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 56.0 days 11 246.0 g 4.0 13.27 body weighing method 0.0 102700 2721
LH/Mav body weight streptozotocin (75 mg/kg) Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 56.0 days 14 248.0 g 4.0 14.97 body weighing method 0.0 102701 2721
LH/Mav body weight streptozotocin (75 mg/kg) Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112.0 days 14 388.0 g 5.0 18.71 body weighing method 0.0 102725 2721
LH/Mav body weight controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119.0 days 8 393.0 g 7.0 19.8 body weighing method 0.0 103405 2824
LH/Mav body weight controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84.0 days 13 327.0 g 7.0 25.24 body weighing method 0.0 103426 2825
LH/Mav body weight controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147.0 days-154.0 days 6 428.0 g 6.0 14.7 body weighing method 0.0 103430 2825
LH/Mav body weight vehicle control condition Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. body mass male 49.0 days-56.0 days 8 232.0 g 6.0 16.97 body weighing method 0.0 102642 2703
LH/Mav body weight control condition Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 8 391.0 g 6.0 16.97 body weighing method 0.0 102787 2723
LH/Mav body weight perindopril (0.1 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 8 404.0 g 6.0 16.97 body weighing method 0.0 102789 2723
LH/Mav body weight control condition Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 8 442.0 g 8.0 22.63 body weighing method 0.0 102801 2723
LH/Mav body weight perindopril (0.04 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 8 442.0 g 6.0 16.97 body weighing method 0.0 102802 2723
LH/Mav body weight perindopril (0.1 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 8 452.0 g 5.0 14.14 body weighing method 0.0 102803 2723
LH/Mav body weight perindopril (0.01 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 161.0 days 6 460.0 g 14.0 34.29 body weighing method 0.0 102806 2723
LH/Mav body weight control condition Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 4 374.0 g 6.0 12.0 body weighing method 0.0 102791 2723
LH/Mav body weight perindopril (0.01 mg/kg/d) (for 98 days) Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. body mass male 112.0 days 6 391.0 g 8.0 19.6 body weighing method 0.0 102792 2723